CMS Modified NCD 68: Hemodialysis for Schizophrenia Is Not a Covered Medicare Benefit

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 68, the National Coverage Determination governing hemodialysis as a treatment for schizophrenia, with an effective date of January 9, 2026. The policy confirms non-coverage. No specific CPT or HCPCS codes are listed in the policy document.

If your team has ever received a claim denial on hemodialysis billed with a psychiatric diagnosis, this policy is why. The CMS hemodialysis for schizophrenia coverage policy is short, direct, and absolute: Medicare does not cover it. What matters for billing teams is understanding why this modification was issued, how to prevent denials before they happen, and what to document if a patient's clinical situation ever blurs the line between renal and psychiatric indications.

Quick-Reference Table

CMS Hemodialysis for Schizophrenia Coverage Criteria and Medical Necessity Requirements 2026

NCD 68 in the Medicare system is one of the cleaner national coverage determinations you'll encounter. There are no tiered criteria. There are no prior authorization pathways that might open a door.

The Centers for Medicare & Medicaid Services reviewed the scientific evidence for hemodialysis as a treatment for schizophrenia and found it inconclusive. That finding drives the entire coverage policy: Medicare does not cover hemodialysis when the purpose is treating schizophrenia. Full stop.

Medical necessity is the standard Medicare uses to determine whether a service is reimbursable. For hemodialysis to meet medical necessity under Medicare, it must be furnished for a covered indication — overwhelmingly, end-stage renal disease (ESRD). When schizophrenia is the stated reason for hemodialysis, the medical necessity standard is not met, and reimbursement will not follow.

This matters most in dual-diagnosis cases. A patient with both schizophrenia and ESRD can and should receive covered hemodialysis for their renal disease. The coverage policy does not prohibit dialysis for that patient. What it prohibits is billing Medicare for hemodialysis when the treatment rationale is psychiatric.

CMS Hemodialysis for Schizophrenia Exclusions and Non-Covered Indications

The exclusion here is narrow but firm. CMS reviewed the evidence, found it inconclusive, and drew a hard line.

Hemodialysis furnished specifically for the treatment of schizophrenia is non-covered under Medicare. There is no mechanism within NCD 68 to override this through prior authorization, additional documentation, or an Advance Beneficiary Notice (ABN) that shifts liability to the patient.

An ABN can inform a patient that Medicare is unlikely to pay. But an ABN does not create a coverage pathway where none exists. If your team is considering billing a Medicare patient out-of-pocket for hemodialysis as a psychiatric treatment, loop in your compliance officer before proceeding — this is the kind of billing scenario that can create liability exposure beyond a simple claim denial.

Coverage Indications at a Glance

Note: NCD 68 does not list specific CPT or HCPCS codes. Coverage status for hemodialysis services billed to Medicare is determined by the diagnosis and the stated clinical indication, not by a code-level inclusion or exclusion list.

CMS Hemodialysis for Schizophrenia Billing Guidelines and Action Items 2026

The modification was effective January 9, 2026. These steps apply now.

NCD 68 and Code Availability

NCD 68 does not list specific CPT or HCPCS codes. This is consistent with how CMS has structured this particular coverage determination — the policy applies based on clinical indication, not based on a defined code set.

Coverage under NCD 68 is determined entirely by the stated treatment rationale. When schizophrenia is the reason for hemodialysis, no code makes the claim covered. There is no code-level workaround here.

What the 2026 Modification Actually Means — and Why It Matters

Some NCD modifications come with significant clinical or billing changes. This one doesn't. The underlying coverage position — hemodialysis for schizophrenia is not covered — has been CMS policy for years.

So why does the modification matter? Because CMS reviewed and reaffirmed this position as of January 9, 2026. That reaffirmation signals that any future claim for hemodialysis with a schizophrenia treatment rationale will be denied with full NCD backing. There is no ambiguity that a billing team can use to argue medical necessity after the fact.

The real issue here is documentation at the point of care. Dialysis facilities and hospitals that treat patients with psychiatric comorbidities need clear internal rules about how treatment rationale gets recorded. If a clinician documents that a dialysis session was intended to address psychiatric symptoms — even as a secondary benefit — that documentation can compromise an otherwise legitimate ESRD claim.

Work with your medical director to establish documentation standards for dual-diagnosis patients receiving hemodialysis. The standard should be simple: document the renal indication. If psychiatric benefit is hypothesized, that goes in a research or case note context, not in the billing-facing clinical record.